ScreenPoint Medical Deploys Transpara® Breast AI at Johns Hopkins to Improve Cancer Detection

by

in

Transpara implemented for clinical use by key thought leaders in radiology and breast imaging.

BALTIMORE, March 12, 2024 /PRNewswire/ — ScreenPoint Medical, announced today that its industry leading Transpara Breast AI is available to improve cancer detection for Johns Hopkins breast cancer screening patients. Transpara assists radiologists with the reading of 2D and 3D mammography exams, providing a ‘second pair’ of eyes to help detect cancers earlier and reduce recall rates. 

The Johns Hopkins Kimmel Cancer Center …

Full story available on Benzinga.com